Organization
Rheumatic Diseases, University of Cape Town, Cape Town, South Africa
2 abstracts
Abstract
102-wk clinical and radiologic results from the attract trial: a 2 year, randomised, controlled, phase 3 trial of infliximab (remicade®) in pts with active ra despite mtxOrg: Centocor, Kennedy Institute of Rheumatology, ATTRACT Investigator, Hammersmith Hospital, Imperial College, London, United Kingdom, Rheumatic Diseases, University of Cape Town, Cape Town, South Africa,
Abstract
"CAPS REGISTRY": A REVIEW OF 200 CASES FROM THE INTERNATIONAL REGISTRY OF PATIENTS WITH CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME (CAPS)Org: Autoimmune Diseases, Hospital Clinic, Barcelona, Spain, Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer, Israel, Internal Medicine, Hôpital Pitié-Salpêtrière, Paris, France, Rheumatic Diseases, University of Cape Town, Cape Town, South Africa,